Helius Medical Technologies to Unveil Q1 2024 Results and Discuss PoNS® U.S. Commercialization

Helius Medical Technologies

NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) is set to announce its financial outcomes for the first quarter of 2024 on Monday, May 13, after the market closure.

Following the release, a conference call led by President and CEO Dane C. Andreeff alongside CFO Jeffrey S. Mathiesen will take place at 4:30 p.m. Eastern Time to elaborate on the financial results and provide a comprehensive business update.

The discussion will particularly focus on the company’s advancements and strategic plans for the U.S. commercialization of its Portable Neuromodulation Stimulator (PoNS®) device.

Interested parties can join the conference through a registered audio-only link or via a webcast, details of which are available on the company’s website. The webcast will also be archived in the Newsroom section for future reference.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Passage Bio Reports Promising Interim Data in FTD-GRN Treatment Trial